NKTR - Nektar Therapeutics - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NKTR (906709)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
69 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-09-28
NKTRAjer Jeffrey RobertDirS - Sale$17.25-3,25025,975-11%-$56,063
2020-09-25
NKTRChess RobertDirS - Sale$17.75-5,500280,573-2%-$97,625
2020-09-17
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale$19.96-2,000235,249-1%-$39,920
2020-09-21
NKTRAjer Jeffrey RobertDirS - Sale$19.74-2,25020,125-10%-$44,415
D
2020-09-08
NKTRChess RobertDirS - Sale+OE$18.53-8,000276,973-3%-$148,240
2020-08-17
NKTRZalevsky JonathanChief R, D OfficerS - Sale$19.67-26,200296,315-8%-$515,354
2020-08-17
NKTRWilson Mark AndrewSVP, GCS - Sale$19.67-1,52951,389-3%-$30,075
2020-08-17
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$19.67-1,367171,733-1%-$26,889
2020-08-17
NKTRRobin Howard WPres, CEOS - Sale$19.67-11,885364,428-3%-$233,778
M
2020-08-17
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale$19.67-8,245237,249-3%-$162,199
D
2020-07-09
NKTRGreer R ScottDirS - Sale+OE$25.00-15,009176,574-8%-$375,225
D
2020-07-08
NKTRChess RobertDirS - Sale+OE$24.58-8,000276,973-3%-$196,640
2020-05-18
NKTRZalevsky JonathanChief R, D OfficerS - Sale$22.51-4,558322,515-1%-$102,601
2020-05-18
NKTRWilson Mark AndrewSVP, GCS - Sale$22.51-1,52952,418-3%-$34,418
2020-05-18
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$22.51-1,367172,719-1%-$30,771
2020-05-18
NKTRRobin Howard WPres, CEOS - Sale$22.51-8,968376,313-2%-$201,870
M
2020-05-18
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale$22.54-7,727245,494-3%-$174,155
D
2020-04-15
NKTRChess RobertDirS - Sale+OE$18.38-8,000276,973-3%-$147,010
D
2020-03-11
NKTRChess RobertDirS - Sale+OE$16.79-8,000276,973-3%-$134,316
2020-02-18
NKTRZalevsky JonathanChief R, D OfficerS - Sale$22.35-4,774327,073-1%-$106,699
2020-02-18
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$22.35-1,394174,086-1%-$31,156
2020-02-18
NKTRRobin Howard WPres, CEOS - Sale$22.35-8,448385,281-2%-$188,813
2020-02-18
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale$22.35-5,938253,221-2%-$132,714
D
2020-02-12
NKTRChess RobertDirS - Sale+OE$23.50-8,000276,973-3%-$188,000
D
2020-02-06
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$22.78-37,500175,480-18%-$854,250
2019-11-18
NKTRZalevsky JonathanChief R, D OfficerS - Sale$17.97-3,960291,697-1%-$71,161
2019-11-18
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$17.97-2,713160,441-2%-$48,753
2019-11-18
NKTRRobin Howard WPres, CEOS - Sale$17.97-13,556299,629-4%-$243,601
2019-11-18
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale$17.97-8,863219,009-4%-$159,268
D
2019-11-13
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale+OE$19.79-25,000227,872-10%-$494,750
DM
2019-10-15
NKTRRobin Howard WPres, CEOS - Sale+OE$17.37-100,000313,185-24%-$1,737,090
D
2019-10-15
NKTRLabrucherie Gil MSVP, COO, CFOS - Sale+OE$15.83-25,000227,872-10%-$395,750
2019-09-27
NKTRLingnau LutzDirS - Sale$17.84-3,00026,700-10%-$53,520
2019-09-30
NKTRAjer Jeffrey RobertDirS - Sale$18.06-2,37522,375-10%-$42,893
2019-09-27
NKTRChess RobertDirS - Sale$17.99-4,000276,973-1%-$71,960
2019-09-20
NKTRAjer Jeffrey RobertDirS - Sale$20.24-2,25018,250-11%-$45,540
D
2019-09-16
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$20.52-25,000152,872-14%-$513,000
2019-09-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerP - Purchase$17.28+15,000107,668+16%+$259,200
2019-08-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$18.15-1,809163,154-1%-$32,833
2019-08-16
NKTRRobin Howard WPres, CEOS - Sale$18.15-12,551283,185-4%-$227,801
2019-08-16
NKTRNicholson JohnSVP, COOS - Sale$18.15-3,819162,759-2%-$69,315
2019-08-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$18.15-5,063122,872-4%-$91,893
2019-08-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$18.15-3,24592,668-3%-$58,897
D
2019-08-14
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$17.79-25,000127,935-16%-$444,750
DM
2019-07-23
NKTRRobin Howard WPres, CEOS - Sale+OE$31.29-100,000295,736-25%-$3,128,667
D
2019-07-10
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$34.57-25,000127,935-16%-$864,250
D
2019-07-08
NKTRLingnau LutzDirS - Sale+OE$34.63-10,00023,200-30%-$346,300
D
2019-06-17
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$33.71-25,000127,935-16%-$842,750
DM
2019-05-21
NKTRRobin Howard WPres, CEOS - Sale+OE$33.00-100,000295,736-25%-$3,300,000
2019-05-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$31.37-1,928164,463-1%-$60,481
2019-05-16
NKTRRobin Howard WPres, CEOS - Sale$31.37-13,383295,736-4%-$419,825
2019-05-16
NKTRNicholson JohnSVP, COOS - Sale$31.37-4,077166,578-2%-$127,895
2019-05-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$31.37-3,767127,935-3%-$118,171
2019-05-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$31.37-2,44994,694-3%-$76,825
2019-05-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$31.37-3,46195,913-3%-$108,572
2019-02-19
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$42.39-1,808166,391-1%-$76,641
DM
2019-02-19
NKTRRobin Howard WPres, CEOS - Sale+OE$42.19-108,882309,119-26%-$4,594,176
2019-02-19
NKTRNicholson JohnSVP, COOS - Sale$42.39-3,822170,655-2%-$162,015
2019-02-19
NKTRLabrucherie Gil MSVP, CFOS - Sale$42.39-3,592131,702-3%-$152,265
2019-02-19
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$42.39-2,38697,143-2%-$101,143
2019-02-19
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$42.39-3,31099,374-3%-$140,311
D
2019-02-04
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$42.16-16,119168,199-9%-$679,577
D
2019-01-28
NKTRNicholson JohnSVP, COOS - Sale+OE$42.82-63,000174,477-27%-$2,697,660
2018-11-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$38.25-4,016157,249-2%-$153,612
2018-11-16
NKTRRobin Howard WPres, CEOS - Sale$38.25-15,326249,551-6%-$586,220
2018-11-16
NKTRNicholson JohnSVP, COOS - Sale$38.25-5,982174,477-3%-$228,812
2018-11-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$38.25-6,515106,544-6%-$249,199
2018-11-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$38.25-4,69481,029-5%-$179,546
2018-11-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$38.25-4,52478,734-5%-$173,043
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top